ESR1 and breast carcinoma: Meanwhile, PIEZO2 expression was found to positively correlate with ER status and PR status but negatively correlate with HER2 status, NPI score, SBR grade, basal-like status and triple-negative status in breast cancer, indicating that high expression of PIEZO2 is closely linked to progression of breast cancer.